Neuropathological Changes of the Intestinal Wall in Patients With Bowel Evacuation Disorders

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEvangelisches Klinikum Köln Weyertal gGmbH

About this trial

Constipation and defecation disorders affect about 15% of the European population and of those up to 30% of the patients over 65 years of age. For those affected, this is associated with major restrictions in quality of life and high health care costs .

The underlying causes of constipation and defecation are complex and only partially understood.

Intestinal (full wall) resections taken in clinical practice from these patients when conservative therapy has been exhausted show rarefaction of ganglion cell nests in the myenteric plexus and submucosal plexus as well as changes in cholinergic innervation.

Initial histopathological investigations suggest an inflammatory genesis of this rarefaction of ganglion cell nests, which will be further characterised/investigated in the context of this study on the basis of further histopathological and serological investigations. This may lead to novel therapeutic approaches that can causally treat the symptoms of those affected.

Eligibility criteria

Qualifiers

obstructive defecation disorder scheduled for surgery

must be able to undergo surgery

> 18 years of age

informed consent

Disqualifiers

no defecation disorder

no surgery needed

unable to undergo surgery

≤ 18 years

Trial design

Treatments tested in this trial

  • blood sample

Treatment groups

No treatment groups listed

Sponsors and collaborators